22157.jpg
Cancer Immunotherapy Market Research 2024: The Race for the Cures - Forecasts for Immuno-Oncology Therapeutics by Therapy, Cancer and Customer including Executive and Consultant Guides
March 13, 2024 11:26 ET | Research and Markets
Dublin, March 13, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Markets. The Race for the Cures. Market Forecasts for Immuno-Oncology Therapeutics by Therapy, by Cancer and by Customer...
22157.jpg
Next-Gen Immuno-Oncology Conference, 7th-8th March 2024 (London, UK) - One Week to Go
February 28, 2024 04:01 ET | Research and Markets
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The "8th Annual Next-Gen Immuno-Oncology Conference" has been added to ResearchAndMarkets.com's offering. Leading the Immunotherapy Revolution -...
Global Biotechnology Contract Manufacturing Market
Biotechnology Contract Manufacturing Market Analysis by Service, Type, Scale, Source, Therapy Area, Molecule Type, and Region - Forecast to 2028 at a Projected Market Value of $24.8 Billion
February 14, 2024 10:00 ET | Research and Markets
Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Biotechnology Contract Manufacturing Market by Service (Manufacturing, Fill Finish, Packaging), Type (Drug Substance, Drug Product), Scale, Source...
22157.jpg
France CAR-T Cell Therapy Market Anticipates Impressive Growth Amid Advances in Personalized Medicine and Increase in Hematological Malignancies
February 12, 2024 04:32 ET | Research and Markets
Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "France CAR-T Cell Therapy Market, By Region, By Competition Forecast & Opportunities, 2018-2028F" report has been added to ...
Global Immuno-oncology Market
Global Immuno-oncology Market Projected at $ 396 Billion by 2034 with a 22.94% CAGR; Asia Pacific to Witness Fastest Growth
February 09, 2024 07:42 ET | Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Immuno-oncology Market" report has been added to ResearchAndMarkets.com's offering.The global immuno-oncology market size was estimated to be...
U.S. Cell and Gene Therapy Clinical Trial Services Market
U.S. Cell and Gene Therapy Clinical Trial Services Market 2024-2030: A $28.58 Billion Opportunity
January 29, 2024 11:34 ET | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "U.S. Cell and Gene Therapy Clinical Trial Services Market Size, Share & Trends Analysis, 2024-2030" report has been added to ...
Global CAR-T Cell Therapy Market
Global CAR-T Cell Therapy Market Report 2024-2034: Accelerated Growth Fueled by Intensive R&D, Growing Medical Recognition, and Fast Track Designation Regulatory Approvals
January 24, 2024 14:23 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. With the...
22157.jpg
Global CAR T-Cell Therapy Research Report 2023: Market Poised for Substantial Growth by 2030, Driven by Advancements in Cancer Treatment and Increasing Incidence Rates
January 24, 2024 04:13 ET | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global CAR T-Cell Therapy Market 2030 by Drug type, Indication, Target Antigen, End-user and Region - Partner & Customer Ecosystem Competitive...
Global Microcarriers Market
Microcarriers Global Market Forecast Report to 2028 - Increasing Demand for Cell-based Vaccines to Drive Market During Forecast Period
December 20, 2023 11:38 ET | Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Microcarriers Market by Product (Equipment (Single Use Bioreactor, SSB, Cell Counter, Culture Vessel, Filtration), Consumables (Media, Reagent), Beads...
22157.jpg
Global Claudin 18.2 Targeted Therapy Research Report 2023-2028: Milestone Approval - Zolbetuximab's FDA Approval Paves the Way as the First CLDN18.2-Targeted Drug
December 15, 2023 05:18 ET | Research and Markets
Dublin, Dec. 15, 2023 (GLOBE NEWSWIRE) -- The "Global Claudin 18.2 Targeted Therapy Market Opportunity & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's...